CJC-1295 with DAC (Drug Affinity Complex) is a modified version of the peptide CJC-1295. The addition of DAC enhances the stability and half-life of the peptide, allowing it to remain active in the body for a longer duration compared to the standard version. CJC-1295 with DAC functions as an analog of growth hormone-releasing hormone (GHRH) and is designed to stimulate the release of growth hormone (GH) from the pituitary gland.